Literature DB >> 26892015

Large-Scale Expansion and Differentiation of Mesenchymal Stem Cells in Microcarrier-Based Stirred Bioreactors.

Sébastien Sart1, Spiros N Agathos2,3.   

Abstract

Mesenchymal stem cells (MSCs) have emerged as an important tool for tissue engineering, thanks to their differentiation potential and their broad trophic activities. However, for clinical purposes or for relevant in vitro applications, large quantities of MSCs are required, which could hardly be reached using conventional cultivation in plastic dishes. Microcarriers have high surface to volume ratio, which enables the easy scale-up of the expansion and differentiation of MSCs. In addition, the agitation in stirred tank bioreactors limits the diffusion gradient of nutrients or morphogens, thus providing a physiologically relevant environment to favor MSC production at large scale. This work describes a simple method for the mass expansion and differentiation of MSCs, including the procedures to monitor the proliferation, metabolic status and phenotype of MSCs during suspension culture. Moreover, this work proposes suitable materials for cGMP compliant culture conditions enabling the clinical grade production of MSCs.

Entities:  

Keywords:  Mesenchymal stem cells; Microcarriers; Spinner flasks; cGMP

Mesh:

Year:  2016        PMID: 26892015     DOI: 10.1007/7651_2015_314

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

1.  Aggregation of Culture Expanded Human Mesenchymal Stem Cells in Microcarrier-based Bioreactor.

Authors:  Xuegang Yuan; Ang-Chen Tsai; Iain Farrance; Jon Rowley; Teng Ma
Journal:  Biochem Eng J       Date:  2017-12-13       Impact factor: 3.978

Review 2.  Mesenchymal stromal cell-based therapy: Regulatory and translational aspects in gastroenterology.

Authors:  Giovanni Dothel; Emanuel Raschi; Roberto Rimondini; Fabrizio De Ponti
Journal:  World J Gastroenterol       Date:  2016-11-07       Impact factor: 5.742

Review 3.  Manufacturing human mesenchymal stem cells at clinical scale: process and regulatory challenges.

Authors:  Valentin Jossen; Christian van den Bos; Regine Eibl; Dieter Eibl
Journal:  Appl Microbiol Biotechnol       Date:  2018-03-22       Impact factor: 4.813

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.